Mitral repair versus replacement for ischemic mitral regurgitation : comparison of short-term and long-term survival

DC FieldValueLanguage
dc.contributor.authorMagne, Julien-
dc.contributor.authorGirerd, Nicolas-
dc.contributor.authorSénéchal, Mario-
dc.contributor.authorMathieu, Patrick-
dc.contributor.authorDagenais, François-
dc.contributor.authorDumesnil, Jean G.-
dc.contributor.authorCharbonneau, Éric-
dc.contributor.authorVoisine, Pierre-
dc.contributor.authorPibarot, Philippe-
dc.date.accessioned2016-06-13T17:28:02Z-
dc.date.available10000-01-01-
dc.date.issued2009-09-15-
dc.identifier.issn0009-7322fr_CA
dc.identifier.urihttp://hdl.handle.net/20.500.11794/4969-
dc.description.abstractBackground— When compared to mitral valve replacement (MVR), mitral valve repair (MVRp) is associated with better survival in patients with organic mitral regurgitation (MR). However, there is an important controversy about the type of surgical treatment that should be used in patients with ischemic MR. The objective of this study was to compare the postoperative outcome of MVRp versus MVR in patients with ischemic MR. Methods and Results— Preoperative and operative data of 370 patients with ischemic MR who underwent mitral valve surgery were prospectively collected and retrospectively analyzed. MVRp was performed in 50% of patients (n 186) and MVR in 50% (n 184). Although operative mortality was significantly lower after MVRp compared to MVR (9.7% versus 17.4%; P 0.03), overall 6-year survival was not statistically different between procedures (73 4% versus 67 4%; P 0.17). After adjusting for other risk factors and propensity score, the type of procedure (MVRp versus MVR) did not come out as an independent predictor of either operative (OR, 1.5; 95% CI, 0.7–2.9; P 0.34) or overall mortality (HR, 1.2; 95% CI, 0.7–1.9; P 0.52). Conclusion— As opposed to what has been reported in patients with organic MR, the results of this study suggest that MVRp is not superior to MVR with regard to operative and overall mortality in patients with ischemic MR. These findings provide support for the realization of a randomized trial comparing these 2 treatment modalities.fr_CA
dc.languageengfr_CA
dc.publisherAmerican Heart Associationfr_CA
dc.subjectIschemiafr_CA
dc.subjectMitral valvefr_CA
dc.subjectProsthesisfr_CA
dc.subjectRegurgitationfr_CA
dc.subjectValvesfr_CA
dc.titleMitral repair versus replacement for ischemic mitral regurgitation : comparison of short-term and long-term survivalfr_CA
dc.typeCOAR1_1::Texte::Périodique::Revue::Contribution à un journal::Article::Article de recherche-
dcterms.bibliographicCitationCirculation, Vol. 120, S104-S111 (2009)fr_CA
dc.audienceProfesseurs (Enseignement supérieur)fr_CA
dc.audienceÉtudiantsfr_CA
dc.audienceDoctorantsfr_CA
dc.audienceCardiologuesfr_CA
dc.audienceMédecinsfr_CA
dc.identifier.doi10.1161/CIRCULATIONAHA.108.843995fr_CA
dc.identifier.pubmed19752354fr_CA
dc.subject.rvmInsuffisance mitralefr_CA
dc.subject.rvmIschémiefr_CA
dc.subject.rvmValvule mitralefr_CA
dc.subject.rvmProthèses valvulaires cardiaquesfr_CA
dc.subject.rvmPronostics (Pathologie)fr_CA
rioxxterms.versionVersion of Recordfr_CA
rioxxterms.version_of_recordhttps://doi.org/10.1161/CIRCULATIONAHA.108.843995fr_CA
rioxxterms.projectMOP 67123fr_CA
rioxxterms.project.funder_nameirscfr_CA
bul.rights.periodeEmbargoInfinifr_CA
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
Description SizeFormat 
Magne2009-11746.pdf
321.3 kBAdobe PDF    Request a copy
All documents in CorpusUL are protected by Copyright Act of Canada.